Novo Nordisk A/S
Compounds For Use in NASH

Last updated:

Abstract:

The present invention relates to compounds for use in the prevention and/or treatment of NASH. The present invention further relates to a method of preventing and/or treating NASH by administering to a subject in need thereof a compound of the invention. Compounds of the invention have been shown to be effective in reducing the relative liver weight (as percentage of total body weight), steatosis, inflammation in the liver and fibrogenesis in the liver.

Status:
Application
Type:

Utility

Filling date:

13 Jun 2019

Issue date:

27 Aug 2020